Related Experiment Videos
Rap1 mutants with increased affinity for the guanine-nucleotide exchange factor C3G
Shuliang Shi1, Makoto Noda, Hitoshi Kitayama
1Department of Molecular Oncology, Kyoto University Graduate School of Medicine, Yoshida-Konoe-cho, Sakyo-ku, Kyoto 606-8501, Japan.
Oncogene
|October 14, 2004
Summary
Researchers engineered a novel Rap1 mutant, Rap1-AGE, that selectively inhibits the C3G protein, a key player in Rap1 signaling. This tool aids in studying the C3G-Rap1 pathway
Area of Science:
- Molecular Biology
- Cell Signaling
- Protein Engineering
Background:
- Ras proteins regulate cellular functions through signaling pathways.
- Ras-17N mutants interfere with wild-type Ras signaling by sequestering guanine-nucleotide exchange factors (GEFs).
- Rap1-17N mutants show limited interference with wild-type Rap1 and its GEF, C3G.
Purpose of the Study:
- To isolate Rap1 mutants with enhanced affinity for C3G.
- To develop a tool for dissecting the C3G-Rap1 signaling pathway.
Main Methods:
- Random mutagenesis and yeast two-hybrid screening to identify Rap1 mutants.
- Site-directed mutagenesis to design Rap1-AGE.
- Co-immunoprecipitation to confirm Rap1-AGE and C3G interaction in cells.
- Functional assays to assess Rap1 activation and cell spreading.
Main Results:
- A potent C3G-binding mutant, Rap1-AGE, was designed with mutations at sites 17A, 29G, and 117E.
- Rap1-AGE successfully associated with C3G in cells and inhibited C3G-mediated Rap1 activation and cell spreading.
- Rap1-AGE did not inhibit Rap1 activation mediated by other GEFs (Epac, smgGDS).
Conclusions:
- Rap1-AGE functions as a dominant interfering factor specifically against C3G.
- Rap1-AGE is a valuable tool for investigating the biological roles of the C3G-Rap1 signaling pathway.